Table 2 H-RAS T81C polymorphism and gastrointestinal cancer risk
Genotype | Gastrointestinal cancer | Gastric cancer | Colon cancer | Rectal cancer | ||||
|---|---|---|---|---|---|---|---|---|
Crude OR (95%CI) | Adjusted OR* (95%CI) | Crude OR (95%CI) | Adjusted OR (95%CI) | Crude OR (95%CI) | Adjusted OR (95%CI) | Crude OR (95%CI) | Adjusted OR (95%CI) | |
TT | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
TC | 1.72(1.22, 2.42) | 1.74(1.23, 2.46) | 3.32(2.06, 5.37) | 3.67(2.21, 6.08) | 1.12(0.65, 1.94) | 1.15(0.66, 1.99) | 1.26(0.76, 2.04) | 1.25(0.77, 2.04) |
CC | 1.74(0.43, 7.03) | 1.66(0.41, 6.77) | 3.69(0.66, 20.73) | 3.29(0.54, 19.86) | 2.50(0.45, 13.91) | 2.57(0.46, 14.46) | - | - |
TC+CC | 1.72(1.23, 2.41) | 1.74(1.24, 2.44) | 3.34(2.08, 5.36) | 3.65(2.22, 6.00) | 1.18(0.70, 2.01) | 1.20(0.71, 2.06) | 1.26(0.76, 2.04) | 1.25(0.77, 2.04) |